Our approach to planning stereotactic I-125 brachytherapy of brain tum
ors has involved least-squares optimization of individual seed positio
ns within the target contour, followed by repeated combining of seeds
from nearest-neighbor catheters in order to achieve an acceptably low
number of catheters and an acceptable separation of entry points. In o
ne option, the catheters diverge from an extra-cranial point that can
be close to the skull if all catheters are to be placed through a smal
l craniectomy to treat a larger-diameter target. In another option, ca
theters converge toward a point beyond the target, to facilitate perpe
ndicularity at the skull surface if a separate opening is to be drille
d for each catheter. In either case, the fact that seed orientations a
re known, permits including anisotropy in dose calculations. Trial see
d locations are constrained to a target region defined on a 1-mm mesh,
both in the initial optimization of single-seed catheters and in subs
equent combinations followed by tune-up optimizations. In the optimiza
tion process, sum-of-squares contributions are weighted more heavily w
hen the dose rate is lower than the target dose rate; the weighting im
balance falls short of keeping all target points above the target dose
rate and requires targeting on a dose rate about 25% higher than the
desired minimum dose rate.